Search research articles
Contact Us
Filters
Showing results (131-140 of 134) with videos related to
Page
of 14
Sort By:
You have reached the last page of results.
This site can display upto 134 results.
Journal of Immunology (Baltimore, Md. : 1950)
|
September 7, 2001
The HA-2 minor histocompatibility antigen is derived from a diallelic gene encoding a novel human class I myosin protein
R A Pierce, E D Field, T Mutis, et al.
The Journal of Biological Chemistry
|
September 20, 1996
Protamines of reptiles
J G Hunt, H E Kasinsky, R M Elsey, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
December 10, 1999
Cutting edge: the HLA-A*0101-restricted HY minor histocompatibility antigen originates from DFFRY and contains a cysteinylated cysteine residue as identified by a novel mass spectrometric technique
R A Pierce, E D Field, J M den Haan, et al.
Cancer Immunology, Immunotherapy : CII
|
February 7, 2001
Melanomas with concordant loss of multiple melanocytic differentiation proteins: immune escape that may be overcome by targeting unique or undefined antigens
C L Slingluff, T A Colella, L Thompson, et al.
Page
of 14
Search research articles
Search
Showing results (131-140 of 134) with videos related to
Sort By:
Page
of 14
You have reached the last page of results.
This site can display upto 134 results.
Journal of Immunology (Baltimore, Md. : 1950)
|
September 7, 2001
The HA-2 minor histocompatibility antigen is derived from a diallelic gene encoding a novel human class I myosin protein
R A Pierce, E D Field, T Mutis, et al.
The Journal of Biological Chemistry
|
September 20, 1996
Protamines of reptiles
J G Hunt, H E Kasinsky, R M Elsey, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
December 10, 1999
Cutting edge: the HLA-A*0101-restricted HY minor histocompatibility antigen originates from DFFRY and contains a cysteinylated cysteine residue as identified by a novel mass spectrometric technique
R A Pierce, E D Field, J M den Haan, et al.
Cancer Immunology, Immunotherapy : CII
|
February 7, 2001
Melanomas with concordant loss of multiple melanocytic differentiation proteins: immune escape that may be overcome by targeting unique or undefined antigens
C L Slingluff, T A Colella, L Thompson, et al.
Page
of 14